TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

9774	Companies
195575	Keywords
126559	Articles
103968	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 08/27/2024 at 07:30, 1 year 5 months ago

Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Transgene announces preclinical proof-of-concept data of oncolytic virus TG6050 published in JITC, showcasing tumor regression and immune remodeling capabilities without systemic toxicity. TG6050 progressing in Phase I trial for NSCLC

Phase I Trial Transgene Oncolytic Virus TG6050 JITC Publication
BRIEF

published on 07/30/2024 at 21:06, 1 year 5 months ago

Transgene consolidates its balance sheet thanks to the conversion of part of the advance into shares

Biotechnology Immunotherapy Increase In Capital Transgene Mérieux Institute
BRIEF

published on 06/03/2024 at 07:35, 1 year 7 months ago

Transgene includes the first patient in Phase II of the study of its TG4050 vaccine against head and neck cancers

Head And Neck Cancer Transgene TG4050 Phase II Therapeutic Vaccine
PRESS RELEASE

published on 06/03/2024 at 07:30, 1 year 7 months ago

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025

Phase II Trial Head And Neck Cancer Cancer Vaccine Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 1 year 8 months ago

Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 1 year 8 months ago

Transgene provides business and financial update for Q1 2024
Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024

Clinical Data Q1 2024 Financial Update Transgene TG4050

Accesswire

Published on 01/30/2026 at 02:15, 5 hours 17 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 7 hours 32 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 8 hours 32 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 12 hours 47 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 13 hours 32 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 07:00, 32 minutes ago

Unbroken record series with high revenue momentum for cloud and subscriptions – 20th record year in a row for revenue and earnings
Published on 01/30/2026 at 04:30, 3 hours 1 minute ago

A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 3 hours 56 minutes ago

Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 7 hours 24 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 10 hours 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc

Les Echos

Published on 01/29/2026 at 18:00, 13 hours 32 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 13 hours 47 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 13 hours 47 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 13 hours 52 minutes ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 21 hours 24 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE